Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-01-29 4:36 pm Sale | 13G | KALA BIO, INC. KALA | INTEGRATED CORE STRATEGIES (US) LLC | 132,674 4.9% | -1,029 (-0.77%) | View |
| 2024-01-26 4:19 pm Sale | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | INTEGRATED CORE STRATEGIES (US) LLC | 6,610 0% | -981,102 (-99.33%) | View |
| 2024-01-25 4:09 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | INTEGRATED CORE STRATEGIES (US) LLC | 3,479,630 5.6% | 3,479,630 (New Position) | View |
| 2024-01-24 4:16 pm Sale | 13G | BIOLIFE SOLUTIONS INC BLFS | INTEGRATED CORE STRATEGIES (US) LLC | 2,412,650 5.4% | -69,296 (-2.79%) | View |
| 2024-01-23 4:31 pm Sale | 13G | MYRIAD GENETICS INC MYGN | INTEGRATED CORE STRATEGIES (US) LLC | 3,561,337 4% | -699,704 (-16.42%) | View |
| 2024-01-22 4:15 pm Sale | 13G | TWIST BIOSCIENCE CORP COM TWST | INTEGRATED CORE STRATEGIES (US) LLC | 1,821,238 3.2% | -1,224,675 (-40.21%) | View |
| 2024-01-22 4:10 pm Sale | 13G | SI-BONE INC SIBN | INTEGRATED CORE STRATEGIES (US) LLC | 1,210,324 3% | -1,066,163 (-46.83%) | View |
| 2024-01-22 4:07 pm Purchase | 13G | EMBECTA CORP COM EMBC | INTEGRATED CORE STRATEGIES (US) LLC | 3,635,948 6.3% | 467,043 (+14.74%) | View |
| 2024-01-19 4:32 pm Sale | 13G | ZIMVIE INC ZIMV | INTEGRATED CORE STRATEGIES (US) LLC | 714,592 2.7% | -763,832 (-51.67%) | View |
| 2024-01-19 4:19 pm Purchase | 13G | HARPOON THERAPEUTICS INC N HARP | INTEGRATED CORE STRATEGIES (US) LLC | 25,465 0.2% | 25,465 (New Position) | View |
| 2024-01-18 4:40 pm Purchase | 13G | NETSTREIT CORP NTST | INTEGRATED CORE STRATEGIES (US) LLC | 3,903,441 5.7% | 3,468,171 (+796.79%) | View |
| 2024-01-17 4:54 pm Purchase | 13G | SUTRO BIOPHARMA INC STRO | INTEGRATED CORE STRATEGIES (US) LLC | 3,451,825 5.7% | 3,451,825 (New Position) | View |
| 2024-01-10 4:22 pm Purchase | 13G | ABEONA THERAPEUTICS INC NE ABEO | INTEGRATED CORE STRATEGIES (US) LLC | 1,418,675 5.7% | 56,576 (+4.15%) | View |
| 2024-01-08 4:32 pm Sale | 13G | AVID BIOSERVICES INC CDMO | INTEGRATED CORE STRATEGIES (US) LLC | 4,240,147 6.7% | -354,880 (-7.72%) | View |
| 2023-12-19 4:05 pm Purchase | 13G | AVID BIOSERVICES INC CDMO | INTEGRATED CORE STRATEGIES (US) LLC | 4,595,027 7.3% | 3,943,316 (+605.07%) | View |
| 2023-12-04 4:09 pm Purchase | 13G | ABEONA THERAPEUTICS INC NE ABEO | INTEGRATED CORE STRATEGIES (US) LLC | 1,362,099 5.5% | 1,362,099 (New Position) | View |
| 2023-11-17 4:05 pm Purchase | 13G | MAXCYTE INC MXCT | INTEGRATED CORE STRATEGIES (US) LLC | 5,770,894 5.6% | 5,770,894 (New Position) | View |
| 2023-10-17 4:14 pm Purchase | 13G | MYRIAD GENETICS INC MYGN | INTEGRATED CORE STRATEGIES (US) LLC | 4,261,041 5.2% | 4,261,041 (New Position) | View |
| 2023-09-26 4:26 pm Purchase | 13G | BIOLIFE SOLUTIONS INC BLFS | INTEGRATED CORE STRATEGIES (US) LLC | 2,481,946 5.7% | 2,481,946 (New Position) | View |
| 2023-09-13 4:29 pm Purchase | 13G | EMBECTA CORP COM EMBC | INTEGRATED CORE STRATEGIES (US) LLC | 3,168,905 5.5% | 3,168,905 (New Position) | View |